E-ISSN 2229-7723 | ISSN 0976-9234
 
2022, Vol: 13, Issue: 2
13/2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Original Article 


Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid

Mays S. Obaid, Sadiq A. Karim, Mohammed H. Said.

Abstract
In the present research, 6-aminopenicillanic acid (6-APA) reaction with(n-butyl aldehyde, crotonaldehyde, terephthalaldehyde, furfuraldehyde) in ethanol to procure compounds [6-(butylidene amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid, 6-(but-2-1-ylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6,6’-((1,4-phenylenebis (methaneylylidene))bis(azaneylylidene))bis(3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid, 6-((furan-2-ylmethylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid] respectively. The structure of synthesized compounds identified by spectral data (FT-IR), ( 1H-NMR), (13C-NMR) spectra and Mass Spectrometric. The Schiff base ligand and synthesis some transition metals complexes [Zn] of this ligand were described via FTIR, UV-Visible Spectroscopy and the Atomic Absorption Spectroscopy, The antibacterial activity of the ligand and complexes was tested against two different bacteria strains (Pseudomonas and Staphylococcus aureus). The ligand and its complexes were discovered to have excellent inhibitory action against bacteria (Pseudomonas and Staphylococcus aureus). As a consequence

Key words: Schiff base, 6-amino penicillanic acid, Schiff base of n-butylaldehyde,Schiff base of crotonaldehyde, Schiff base of terephthaldehyde, Schiff base of furfural


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mays S. Obaid
Articles by Sadiq A. Karim
Articles by Mohammed H. Said
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Obaid MS, Karim SA, Said MH. Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. PNR. 2022; 13(2): 97-101. doi:10.47750/pnr.2022.13.02.015

Web Style

Obaid MS, Karim SA, Said MH. Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. https://www.pnrjournal.com/?mno=55954 [Access: August 11, 2022]. doi:10.47750/pnr.2022.13.02.015

AMA (American Medical Association) Style

Obaid MS, Karim SA, Said MH. Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. PNR. 2022; 13(2): 97-101. doi:10.47750/pnr.2022.13.02.015


Vancouver/ICMJE Style

Obaid MS, Karim SA, Said MH. Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. PNR. (2022), [cited August 11, 2022]; 13(2): 97-101. doi:10.47750/pnr.2022.13.02.015


Harvard Style

Obaid, M. S., Karim, . S. A. & Said, . M. H. (2022) Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. PNR, 13 (2), 97-101. doi:10.47750/pnr.2022.13.02.015


Turabian Style

Obaid, Mays S., Sadiq A. Karim, and Mohammed H. Said. 2022. Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. Journal of Pharmaceutical Negative Results, 13 (2), 97-101. doi:10.47750/pnr.2022.13.02.015


Chicago Style

Obaid, Mays S., Sadiq A. Karim, and Mohammed H. Said. "Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid." Journal of Pharmaceutical Negative Results 13 (2022), 97-101. doi:10.47750/pnr.2022.13.02.015


MLA (The Modern Language Association) Style

Obaid, Mays S., Sadiq A. Karim, and Mohammed H. Said. "Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid." Journal of Pharmaceutical Negative Results 13.2 (2022), 97-101. Print. doi:10.47750/pnr.2022.13.02.015


APA (American Psychological Association) Style

Obaid, M. S., Karim, . S. A. & Said, . M. H. (2022) Synthesis, Characterization and Antibacterial Evaluation of New Schiff Base Ligand and Its Complexes of Transition Metal Ion Zn (II), based on 6-Aminopenicillanic Acid. Journal of Pharmaceutical Negative Results, 13 (2), 97-101. doi:10.47750/pnr.2022.13.02.015


Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights) Privacy Policy Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Journal of Pharmaceutical Negative Results are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2022 Journal of Pharmaceutical Negative Results All Rights Reserved. Subject to change without notice from or liability to Journal of Pharmaceutical Negative Results.
For best results, please use Internet Explorer or Google Chrome

Contact Information


  ResearchTrentz

 Scientific Research Community 

Contact US

21, First Floor,ResearchTrentz (Registred Office)
                          Thamotharan Street,India

 Email : editorial@pnrjournal.com, Support : pnrjournal@gmail.com